Mirko Scarsi
About
In The Last Decade
Mirko Scarsi
18 papers receiving 440 citations
Peers
Comparison fields: 5 of 60
- Immunology 218
- Rheumatology 181
- Pathology and Forensic Medicine 86
- Epidemiology 65
- Radiology, Nuclear Medicine and Imaging 63
Countries citing papers authored by Mirko Scarsi
This map shows the geographic impact of Mirko Scarsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Scarsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Scarsi more than expected).
Fields of papers citing papers by Mirko Scarsi
This network shows the impact of papers produced by Mirko Scarsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Scarsi. The network helps show where Mirko Scarsi may publish in the future.
Co-authorship network of co-authors of Mirko Scarsi
This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Scarsi. A scholar is included among the top collaborators of Mirko Scarsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirko Scarsi. Mirko Scarsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 9 | |
| 3 | 16 | |
| 4 | 5 | |
| 5 | Serum levels of granzyme B decrease in patients with rheumatoid arthritis responding to abatacept. | 5 |
| 6 | Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'. | 13 |
| 7 | 17 | |
| 8 | 16 | |
| 9 | 55 | |
| 10 | 4 | |
| 11 | 33 | |
| 12 | 50 | |
| 13 | 11 | |
| 14 | 54 | |
| 15 | 73 | |
| 16 | 45 | |
| 17 | 25 | |
| 18 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.